Almac Clinical Technologies Named One of the 'Best Places to Work in PA 2009'
Yardley, PA
Almac Clinical Technologies announced that it has been named one of the Best Places to Work in PA for 2009. The awards program, created in 2000, is one of the first statewide programs of its kind in the country. It consists of a public/private partnership between Team Pennsylvania Foundation, the Pennsylvania Department of Community and Economic Development, the Pennsylvania Chamber of Business and Industry and the Central Penn Business Journal.
This survey and awards program was designed to identify, recognize and honor the best places to be employed in Pennsylvania. It is intended to acknowledge companies that have established a dynamic and productive working environment for their employees.
Companies from across the state entered the two-part process to determine the 100 Best Places to Work in PA. The first part consisted of evaluating each nominated company's workplace policies, practices, philosophies, systems and demographics. The second part consisted of an employee survey to measure the employee experience. The combined scores of both parts determined the top companies and the final ranking. Best Companies Group managed the overall registration and survey process.
Almac Clinical Technologies will be recognized at the Best Places to Work in PA evening awards ceremony on Tuesday, December 1, 2009, at the Hershey Lodge & Convention Center in Hershey, PA. Rankings will be revealed at the ceremony.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
